Analyst firms · Chardan Capital Markets · CRVO

Chardan Capital Markets CRVO price target and rating history

CervoMed Inc. (CRVO) · Health Care

Chardan Capital Markets rates CervoMed Inc. (CRVO) Buy with a $14 price target, as of its latest action on Mar 13, 2025. It has published 3 rating actions on CRVO since September 2024, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$14
Median target, all firms
Too few
Actions on CRVO
3

Chardan Capital Markets price target on CRVO

$55$35$1420252026
Chardan Capital Markets price target on CRVO, each point a stated target, September 2024 to March 2025.

Every Chardan Capital Markets rating on CRVO

Questions about Chardan Capital Markets and CRVO

What is Chardan Capital Markets's price target for CRVO?
Chardan Capital Markets's latest stated price target for CervoMed Inc. (CRVO) is $14, from its action on Mar 13, 2025.
What is Chardan Capital Markets's rating on CRVO?
Chardan Capital Markets rates CRVO Buy, a bullish rating, as of Mar 13, 2025.
When did Chardan Capital Markets last change its view on CRVO?
On Mar 13, 2025, Chardan Capital Markets upgrades to Buy from Neutral, price target $14.

All Chardan Capital Markets ratingsCRVO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.